YPSOMED HOLDING AGYPSOMED HOLDING AGYPSOMED HOLDING AG

YPSOMED HOLDING AG

No trades
See on Supercharts

OWX fundamentals

An in-depth look to YPSOMED HOLDING AG operating, investing, and financing activities

OWX free cash flow for H2 24 is -25.76 M CHF. For 2024, OWX free cash flow was -57.4 M CHF and operating cash flow was 148.2 M CHF.

Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CHF
TTM
Free cash flowYoY growth